Lindbrook Capital, LLC Atara Biotherapeutics, Inc. Transaction History

Lindbrook Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 24, 2023	SELL	$2.85 - $5.18 $1,074 - $1,952	-377 Reduced 76.01%	119 $0
Q3 2022 Nov 10, 2022	BUY	$2.85 - $8.73 $698 - $2,138	245 Added 97.61%	496 $2,000
Q2 2022 Aug 01, 2022	BUY	$4.69 - $9.84 $1,177 - $2,469	251 New	251 $2,000
Q2 2021 Jul 27, 2021	SELL	$12.89 - $16.58 $760 - $978	-59 Closed	0 $0
Q3 2020 Nov 03, 2020	SELL	$11.92 - $15.87 $3,599 - $4,792	-302 Reduced 83.66%	59 $1,000

Q2 2020 Jul 27, 2020	BUY	$7.53 - $14.93 $2,718 - $5,389	361 New	361 $5,000

85M

18.4K

51.3K

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $781M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.